Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 2—February 2006

Borrelia burgdorferi and Anaplasma phagocytophilum Coinfection

Micha Loebermann*, Volker Fingerle†, Matthias Lademann*, Carlos Fritzsche*, and Emil C. Reisinger*Comments to Author 
Author affiliations: *University of Rostock Medical School, Rostock, Germany; †Ludwig-Maximilian-Universität München, Munich, Germany

Main Article


Results of serologic tests at diagnosis and during follow-up*

Time (d) after onset of symptoms Anaplasma (Ehrlichia) phagocytophilum (IFA)†
Borrelia burgdorferi (ELISA)‡
Borrelia burgdorferi (Immunoblot)§
6 Negative (<1:20) Negative (<1:32) Negative Negative Negative Negative
10 ND ND Positive Negative ND ND
28 Positive (1:40) Negative (1:32) Positive Negative Positive Negative
107 Positive (1:20) Negative (<1:32) Positive Negative Positive Negative
380 Negative (<1:20) Negative (<1:32) Equivocal Negative Positive Negative

*Symptoms (fever, headache, myalgia) started 6 days before presentation. IFA, immunofluorescent assay; ELISA, enzyme-linked immunosorbent assay; Ig, immunoglobulin; ND, not done.
†Genzyme Virotech, Germany. Positive titers: IgM >1:20, IgG >1:64.
‡Behring, Germany.
§In-house Immunoblot, Max von Pettenkofer-Institut, Munich, Germany.

Main Article

Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.